CN104958486A - Traditional Chinese medicine for treating lymphatic tuberculosis - Google Patents
Traditional Chinese medicine for treating lymphatic tuberculosis Download PDFInfo
- Publication number
- CN104958486A CN104958486A CN201510438569.0A CN201510438569A CN104958486A CN 104958486 A CN104958486 A CN 104958486A CN 201510438569 A CN201510438569 A CN 201510438569A CN 104958486 A CN104958486 A CN 104958486A
- Authority
- CN
- China
- Prior art keywords
- powder
- chinese medicine
- parts
- traditional chinese
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a traditional Chinese medicine for treating lymphatic tuberculosis. The traditional Chinese medicine comprises the following components: pseudo-ginseng, saffron crocus, wadalee-gum-tree, frankincense, myrrh, cinnabar, sangusis draconis, borneol, musk, talcum powder or white powder. The traditional Chinese medicine is used for specially treating diabrosis and trauma of lymphatic tuberculosis. According to the invention, the lymphatic tuberculosis is treated with the powder or paste disclosed by the invention; the traditional Chinese medicine has the efficacies of clearing away heat and toxic materials, promoting blood circulation, removing noxious pathogen attack and degassing, is a good medicine for invigorating blood circulation, reducing swelling, converging, removing the necrotic tissue and promoting granulation, and has actually special effects through clinical application for more than twenty years; the traditional Chinese medicine disclosed by the invention has the effects of high recovery speed, high recovery rate, difficult recurring and low lymphatic tuberculosis treatment cost; the course of the disease of a patient is shortened; the pain of the patient is relieved; and meanwhile, the economical burdens of the patients are reduced.
Description
Technical field:
The present invention relates to the field of Chinese medicines, particularly relate to one and treat scrofulous Chinese medicine.
Background technology:
Lymphoid tuberculosis, the systemic toxicity profiles symptoms such as the traditional Chinese medical science is referred to as scrofula, is among the peoplely called " lymphoid tuberculosis ", repeatedly festers, and small part patient can have low grade fever, inappetence, become thin are the tumor tissue being embodied in flesh table, are condensed into by the expectorant poison of liver lung two aspect, pyretic toxicity.Western medicine universities is thought, lymphoid tuberculosis is that the lymph node tissue caused by mycobacterium tuberculosis infection is destroyed.How at cervical region side or bilateral, oxter, thoracic wall, when body immunity is low, or when having pulmonary Mycobacterium to infect, the lung tuberculosis outward of generation.At the initial stage, clinical symptoms shows as local enlargement, and low grade fever, weak, night sweat, tuberculin test is strong positive, and the later stage is local organization enlargement, ulceration, and flowing water sample pus also discharges the cheesy pus of yellow turbid sample.
At present, western medical treatment generally adopts tuberculosis therapeutic regimen, as 2HRZE/4HR (H: isoniazid; R: rifampicin; Z: pyrazinamide; E: ethambutol), 3HRZS (E)/9HR (H: isoniazid, R: rifampicin, S: streptomycin, Z: pyrazinamide, E: ethambutol), 2DL2ZS/4DL2 (D: Dipasic, L: rifapentine, Z: pyrazinamide, S: streptomycin) etc.But antituberculotics makes to organize drug concentration to be difficult to reach effective bacteriocidal concentration because being difficult to penetrate pathological tissues mostly, can not realize effective bactericidal action; Or make Endodontic failure because of untoward reaction such as liver function injury.Operative treatment coordinates antituberculosis drugs treat, can improve curative effect to a certain extent, but preoperative and postoperative administration time is of a specified duration, and the course for the treatment of is longer, once drug withdrawal, normal easily recurrence, expense also costly.And, for formed cold abscess or diabrosis form the patient of the prolonged sinus tract that do not heal or ulcer, cannot cure with Western medicine at all.
Summary of the invention:
The object of the present invention is to provide that cure rate is high, treatment time is short, greatly reduce the scrofulous Chinese medicine for the treatment of of patient suffering.
Object of the present invention is implemented by following technical scheme, and it comprises following component: Radix Notoginseng; Stigma Croci; Catechu; Olibanum; Myrrha; Cinnabaris; Sanguis Draxonis; Borneolum Syntheticum; Moschus moschiferous is fragrant; Talcum is ground into powder or official's powder.
Further, it also includes Lignum Dalbergiae Odoriferae and grinds into powder and Gypsum Fibrosum Preparatum.
Further, it also includes Cera Flava; Adeps Sus domestica; Oleum sesami.
Concrete, the scrofulous Chinese medicine of described treatment, each component is by following weight: Radix Notoginseng 2-10 part; Stigma Croci 2-10 part; Catechu 4-10 part; Olibanum 2-10 part; Myrrha 2-10 part; Cinnabaris 8-20 part; Sanguis Draxonis 8-20 part; Borneolum Syntheticum 3-10 part; Moschus 2-8 part; Talcum grinds 20-50 part or official's powder 3-7 part into powder.
Concrete, the scrofulous Chinese medicine of described treatment, each component is by following weight: Radix Notoginseng 2-10 part; Stigma Croci 2-10 part; Catechu 4-10 part; Olibanum 2-10 part; Myrrha 2-10 part; Cinnabaris 8-20 part; Sanguis Draxonis 8-20 part; Borneolum Syntheticum 3-10 part; Moschus 2-8 part; Talcum grinds 20-50 part or official's powder 3-7 part into powder; Lignum Dalbergiae Odoriferae grinds 3-7 part into powder; Gypsum Fibrosum Preparatum 10-40 part.
Concrete, the scrofulous Chinese medicine of described treatment, each component is by following weight: Radix Notoginseng 2-10 part; Stigma Croci 2-10 part; Catechu 4-10 part; Olibanum 2-10 part; Myrrha 2-10 part; Cinnabaris 8-20 part; Sanguis Draxonis 8-20 part; Borneolum Syntheticum 3-10 part; Moschus 2-8 part; Talcum grinds 20-50 part or official's powder 3-7 part into powder; Lignum Dalbergiae Odoriferae grinds 3-7 part into powder; Gypsum Fibrosum Preparatum 10-40 part; Cera Flava 50-100 part; Adeps Sus domestica 100-200 part; Oleum sesami 200-400 part.
Concrete, obtained pharmaceutical formulation is powder.
Concrete, obtained pharmaceutical formulation is unguentum.
Medicine of the present invention be select Radix Notoginseng, Stigma Croci, catechu, Olibanum, Myrrha, Cinnabaris, Sanguis Draxonis, Borneolum Syntheticum, Moschus, Talcum are ground into powder, Lignum Dalbergiae Odoriferae is ground into powder and combined with medicines such as Gypsum Fibrosum Preparatum, and coordinates Cera Flava, Adeps Sus domestica and Oleum sesami to make unguentum.These medicines are combined, makes each efficacy of drugs produce synergism, thus can rapid healing lymphoid tuberculosis, particularly to forming cold abscess or diabrosis has formed the prolonged sinus tract that do not heal or ulcer patient has fabulous therapeutic effect.Wherein, Radix Notoginseng: warm in nature, sweet in the mouth, micro-hardship, have dissipating blood stasis hemostasis, subduing swelling and relieving pain, promoting blood circulation and hemostasis, the effect of clots absorbing of promoting blood circulation, modern medicine study Radix Notoginseng, containing ginsenoside and arasaponin, has antibacterial effect, has inhibitory action to golden Fructus Vitis viniferae fungus, escherichia coli; Stigma Croci: sweet in the mouth GUIXIN Liver Channel cold in nature, main blood circulation promoting and blood stasis dispelling, stimulate the menstrual flow removing heat from blood, the effect of promoting blood circulation of purging heat of detoxifying, and generic name precious medicinal material is main containing carthamin; Catechu: removing dampness sore, promoting regeneration of the tissue and arresting bleeding, pained cool, return lung meridian, for eczema flowing water, ulcer being unable to heal, aphtha and traumatic hemorrhage etc.; Olibanum: arduous temperature, enters conscience spleen channel, have relaxing muscles and tendons to promote blood circulation, granulation promoting pain relieving, for rheumatic Bi syndrome, traumatic injury, congestion swells and ache, and external energy poison holding disappears bitterly, promoting tissue regeneration and ulcer healing, and relaxing muscles and tendons to promote blood circulation is external application traumatology key medicine; Lignum Dalbergiae Odoriferae is ground into powder: pungent, warm, and GUIXIN Liver Channel has effect of promoting blood circulation to remove blood stasis, pain relieving, and " Compendium of Materia Medica " is chatted, and treats injured incised wound, hemostasis analgesic therapy, detumescence and promoting granulation; Gypsum Fibrosum Preparatum is ground into powder: in pungent, sweet, Great Cold, return lung meridian, have clearing away heat-fire, effect that relieving restlessness is quenched the thirst.Gypsum Fibrosum Preparatum can outward for skin infection burst and do not hold back, eczema, burn due to hot liquid or fire etc., have the effect of heat clearing away convergence; Myrrha: bitter, flat, enters Liver Channel.Have dissipating blood stasis for subsidence of swelling, granulation promoting pain relieving, pharmacological research finds its resinous, volatile oil.Resin has inhibitory action to multiple bacterium; Cinnabaris: sweet, be slightly cold, enter heart channel, main Containing Sulfur hydrargyrum, outward for wound, tool anti-corrosive antibacterial, controls the effects such as sore swollen toxin.Enter heart heat clearing away, calm the nerves, relieving convulsion; Sanguis Draxonis: sweet, salty, flat, GUIXIN Liver Channel, has hemostasia and promoting granulation, sore, for oral administration to invigorate blood circulation, scattered silt pain relieving, is mainly used to traumatic hemorrhage, ulcer being unable to heal, has effect of hemostasis, promoting tissue regeneration and ulcer healing; Borneolum Syntheticum: pungent, bitter, be slightly cold, enters conscience lung meridian.Have clearing away heat to alleviate pain of having one's ideas straightened out, cure mainly calentura coma, apoplexy toxic stupor, have refreshment effect of having one's ideas straightened out, external can control skin ulcer pain toxic swelling, loose stagnated fire, for heat-clearing and toxic substances removing pain relieving good medicine, aphtha are particularly conventional.Modern medicine study finds, Borneolum Syntheticum has antiinflammatory, antibacterial action, alleviates edema, suppresses harmful structure hypertrophy etc.; Moschus: warm in nature, acrid in the mouth, gas fragrance, has effect of refreshment of having one's ideas straightened out, blood circulation promoting and dispersing pathogen accumulation, is usually used in dispersing swelling and dissipating binds, controls swollen ulcer drug, laryngopharynx swelling and pain, traumatic injury etc., modern pharmacy is studied: main containing muscone-polypeptide, excitation is risen for central nervous system, cardiovascular system, strengthens myocardial contraction, also have anti-to swell and ache, antiinflammatory, suppress S. aureus L-forms, hog cholera bacterium, colibacillary growth, have destruction to sarcoma, ehrlich carcinoma; Talcum is ground into powder: acrid in the mouth, sweet, cold, enters stomach urinary bladder channel, has and control pyretic toxicity, dislikes furuncle and all skin ulcers are swollen, effect of relieving stranguria by diuresis, clearing away summer-heat, removing dampness sore.
Advantage of the present invention: Chinese medicine of the present invention specially controls lymphoid tuberculosis diabrosis and wound.Utilize powder of the present invention or unguentum treatment lymphoid tuberculosis, there is heat-clearing and toxic substances removing, promoting blood circulation, except attacked by pestiferous factors, degassing, be promoting blood circulation and detumescence, the good medicine of convergence, removing the necrotic tissue and promoting granulation, clinical practice two truly has specially good effect during the last ten years.By treatment by Chinese herbs lymphoid tuberculosis of the present invention, have and cure soon, cure rate is high, not easily recurs, and shortens patient's course of disease, and reduce patient suffering, meanwhile, medical expense is low, reduces the financial burden of patient.
Detailed description of the invention:
Embodiment 1: treat scrofulous Chinese medicine, each component is by following weight: Radix Notoginseng 2 parts; Stigma Croci 2 parts; 4 parts, catechu; Olibanum 2 parts; Myrrha 2 parts; 8 parts, Cinnabaris; Sanguis Draxonis 8 parts; Borneolum Syntheticum 3 parts; 2 parts, Moschus; Talcum grinds 20 parts into powder; Lignum Dalbergiae Odoriferae grinds 5 parts into powder; Gypsum Fibrosum Preparatum 10 parts; 50 parts, Cera Flava; Adeps Sus domestica 100 parts; Oleum sesami 200 parts.Said medicine conventional method is made unguentum.
Embodiment 2: treat scrofulous Chinese medicine, each component is by following weight: Radix Notoginseng 10 parts; Stigma Croci 10 parts; 10 parts, catechu; Olibanum 10 parts; Myrrha 10 parts; 20 parts, Cinnabaris; Sanguis Draxonis 20 parts; Borneolum Syntheticum 10 parts; 8 parts, Moschus; Talcum grinds 50 parts into powder; Lignum Dalbergiae Odoriferae grinds 10 parts into powder; Gypsum Fibrosum Preparatum 40 parts; 100 parts, Cera Flava; Adeps Sus domestica 200 parts; Oleum sesami 400 parts.Said medicine conventional method is made unguentum.
Embodiment 3: treat scrofulous Chinese medicine, each component is by following weight: Radix Notoginseng 6 parts; Stigma Croci 6 parts; 7 parts, catechu; Olibanum 6 parts; Myrrha 6 parts; 14 parts, Cinnabaris; Sanguis Draxonis 14 parts; Borneolum Syntheticum 7 parts; 5 parts, Moschus; Talcum grinds 35 parts into powder; Lignum Dalbergiae Odoriferae grinds 8 parts into powder; Gypsum Fibrosum Preparatum 25 parts; 75 parts, Cera Flava; Adeps Sus domestica 150 parts; Oleum sesami 300 parts.Said medicine conventional method is made unguentum.
Embodiment 4: treat scrofulous Chinese medicine, each component is by following weight: Radix Notoginseng 2 parts; Stigma Croci 2 parts; 4 parts, catechu; Olibanum 2 parts; Myrrha 2 parts; 8 parts, Cinnabaris; Sanguis Draxonis 8 parts; Borneolum Syntheticum 3 parts; 2 parts, Moschus; Talcum grinds 20 parts into powder; Lignum Dalbergiae Odoriferae grinds 5 parts into powder; Gypsum Fibrosum Preparatum 10 parts.Said medicine conventional method is made powder.
Embodiment 5: treat scrofulous Chinese medicine, each component is by following weight: Radix Notoginseng 10 parts; Stigma Croci 10 parts; 10 parts, catechu; Olibanum 10 parts; Myrrha 10 parts; 20 parts, Cinnabaris; Sanguis Draxonis 20 parts; Borneolum Syntheticum 10 parts; 8 parts, Moschus; Talcum grinds 50 parts into powder; Lignum Dalbergiae Odoriferae grinds 10 parts into powder; Gypsum Fibrosum Preparatum 40 parts.Said medicine conventional method is made powder.
Embodiment 6: treat scrofulous Chinese medicine, each component is by following weight: Radix Notoginseng 6 parts; Stigma Croci 6 parts; 7 parts, catechu; Olibanum 6 parts; Myrrha 6 parts; 14 parts, Cinnabaris; Sanguis Draxonis 14 parts; Borneolum Syntheticum 7 parts; 5 parts, Moschus; 7 parts, official's powder; Lignum Dalbergiae Odoriferae grinds 8 parts into powder; Gypsum Fibrosum Preparatum 25 parts; 75 parts, Cera Flava; Adeps Sus domestica 150 parts; Oleum sesami 300 parts.Said medicine conventional method is made powder.
Embodiment 7: Outcome measure cure: lump dissipate or ulcer, sinus tract healing, General Symptoms disappear; Effective: abscess significantly reduces, ulcer, sinus tract heal substantially, and symptom major part disappears; Effective: abscess obviously reduces and there is no diabrosis tendency; Ulcer, sinus tract are comparatively front to take a turn for the better, and General Symptoms improves; Invalid: lump does not disappear, sinus tract disunion, General Symptoms does not improve.
Randomly draw the 156 routine lymphoid tuberculosis patients with treatment by Chinese herbs of the present invention, wherein, 0-20 year patient 42 example, mean treatment 10 days, cures 41 people, effective 1 people; 21-40 year patient 69 example, mean treatment 12 days, cures 66 people, effective 2 people, effective 1 people; 40-60 year patient 45 example, mean treatment 14 days, cures 42 people, effective 2 people, effective 1 people.Randomly draw 156 routine lymphoid tuberculosis patients, total cure rate reaches 95.5%.
Model case:
1, Zhang, man, nineteen forty-one life on October 15, left clavicle lower wall lymphoid tuberculosis, the inspection smear tubercule bacillus positive (+++), in June, 2013, row lymphoid tuberculosis focus disappeared wound art, be in hospital 63 days, after wound conventional western medicine is changed dressings 45 days, the degree of depth 14 centimeters in sinus tract, secretions and ulcerated tissue flow out, obstinate.In JIUYUE, 2013, with unguentum of the present invention treatment, in wound, sinus tract smears unguentum of the present invention, within every two days, changes dressings once, and change dressings after five times, in wound, sinus tract cambium is long flat, and recovery from illness of forming a scab after 13 days, follows up a case by regular visits to and do not recur.
2, certain is paid, female, 1989.1.12 raw, peasant, the enlargement of submandibular lymph nodes ulceration, disappear through hospital's row focus and create postoperative wound obstinate, join simultaneously and take anti-scarring agent, 2012.9-2013.1, route dressing change, granulation tissue does not grow, and patient is often in secretions and ulcerated tissue under low grade fever's inflammation, jaw and comes off under state.With unguentum of the present invention treatment, within every two days, change dressings 1 time, change dressings after 4 times, the growth of He Xia new granulation tissue, incrustation, healing, follow up a case by regular visits to and do not recur.
3, Wang, man, the birth on the 16th of nineteen forty-three December, diagnosis right side thoracic tuberculosis, in May, 2010 goes to a doctor, and affected part wound hematoma is rotten, the degree of depth 8 centimeters, after the cleaning of wound blood epluchage, with unguentum treatment of the present invention, wound innerlich anwenden, within every 2 days, with after normal saline cleaning, change dressings the next day of row once, grow with through 10 Tian Hou new granulation tissues, incrustation recovery from illness in 12 days, follows up a case by regular visits to and does not recur.
4, Yao, nineteen fifty-seven life on April 19, female, on June 4th, 2008 enters out-patient treatment, patient temperature: 37.6 degree, diagnosis: right subclavian lymphoid tuberculosis, postoperative through focal cleaning, with unguentum treatment of the present invention, every 2-3 days changes dressings once, the sinus tract degree of depth 8 centimeters under clavicle at that time, medication is formed a scab after 17 days recovery from illness, follows up a case by regular visits to and does not recur.
5, Lee, man, life on March 13 in 2008.Medical diagnosis: right axillary gland core, secretions smear, the tubercule bacillus positive (++) tuberculin PPD1.5 centimetre, be positive blister.Outpatient service focal cleaning is postoperative, with unguentum treatment of the present invention, within every 2 days, changes dressings once, fully recovers, follow up a case by regular visits to and do not recur after 7 times.
6, Zhang, man, in nineteen ninety out-patient treatment, the left lymphoid tuberculosis of diagnosis thoracic wall, detect tubercule bacillus (++) in ulcer shape smear positive, patient is wound and sinus tract disunion after surgical intervention, again through conventional dressing change 25 days, do not grow granulation tissue, carry out my outpatient service through with unguentum treatment of the present invention, every 2-3 days changes dressings once, after 21 days, and new tissue growth, 12 centimeters of sinus tracts grow granulation tissue, concordant with wound, incrustation recovery from illness, follows up a case by regular visits to and does not recur.
In sum: this Chinese medicine preparation is treatment lymphoid tuberculosis specific medicament, and not only relapse rate is low, and can conditions of patients recovery from illness at short notice.
Claims (8)
1. treat scrofulous Chinese medicine, it is characterized in that, it comprises following component: Radix Notoginseng; Stigma Croci; Catechu; Olibanum; Myrrha; Cinnabaris; Sanguis Draxonis; Borneolum Syntheticum; Moschus moschiferous is fragrant; Talcum is ground into powder or official's powder.
2. the scrofulous Chinese medicine for the treatment of according to claim 1, is characterized in that, it also includes Lignum Dalbergiae Odoriferae and grinds into powder and Gypsum Fibrosum Preparatum.
3. the scrofulous Chinese medicine for the treatment of according to claim 2, it is characterized in that, it also includes Cera Flava; Adeps Sus domestica; Oleum sesami.
4. the scrofulous Chinese medicine for the treatment of according to claim 1, is characterized in that, each component is by following weight: Radix Notoginseng 2-10 part; Stigma Croci 2-10 part; Catechu 4-10 part; Olibanum 2-10 part; Myrrha 2-10 part; Cinnabaris 8-20 part; Sanguis Draxonis 8-20 part; Borneolum Syntheticum 3-10 part; Moschus 2-8 part; Talcum grinds 20-50 part or official's powder 3-7 part into powder.
5. the scrofulous Chinese medicine for the treatment of according to claim 2, is characterized in that, each component is by following weight: Radix Notoginseng 2-10 part; Stigma Croci 2-10 part; Catechu 4-10 part; Olibanum 2-10 part; Myrrha 2-10 part; Cinnabaris 8-20 part; Sanguis Draxonis 8-20 part; Borneolum Syntheticum 3-10 part; Moschus 2-8 part; Talcum grinds 20-50 part or official's powder 3-7 part into powder; Lignum Dalbergiae Odoriferae grinds 3-7 part into powder; Gypsum Fibrosum Preparatum 10-40 part.
6. the scrofulous Chinese medicine for the treatment of according to claim 3, is characterized in that, each component is by following weight: Radix Notoginseng 2-10 part; Stigma Croci 2-10 part; Catechu 4-10 part; Olibanum 2-10 part; Myrrha 2-10 part; Cinnabaris 8-20 part; Sanguis Draxonis 8-20 part; Borneolum Syntheticum 3-10 part; Moschus 2-8 part; Talcum grinds 20-50 part or official's powder 3-7 part into powder; Lignum Dalbergiae Odoriferae grinds 3-7 part into powder; Gypsum Fibrosum Preparatum 10-40 part; Cera Flava 50-100 part; Adeps Sus domestica 100-200 part; Oleum sesami 200-400 part.
7. the scrofulous Chinese medicine of the treatment according to claim 4 or 5, is characterized in that, obtained pharmaceutical formulation is powder.
8. the scrofulous Chinese medicine for the treatment of according to claim 6, is characterized in that, obtained pharmaceutical formulation is unguentum.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510438569.0A CN104958486A (en) | 2015-07-23 | 2015-07-23 | Traditional Chinese medicine for treating lymphatic tuberculosis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510438569.0A CN104958486A (en) | 2015-07-23 | 2015-07-23 | Traditional Chinese medicine for treating lymphatic tuberculosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104958486A true CN104958486A (en) | 2015-10-07 |
Family
ID=54212689
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510438569.0A Pending CN104958486A (en) | 2015-07-23 | 2015-07-23 | Traditional Chinese medicine for treating lymphatic tuberculosis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104958486A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105943790A (en) * | 2016-06-27 | 2016-09-21 | 蒋丁贵 | Traditional Chinese medicine for treating noxious pathogen attack and preparation method thereof |
| CN115154550A (en) * | 2022-07-26 | 2022-10-11 | 首都医科大学附属北京胸科医院 | External traditional Chinese medicine composition for treating ulcer type tuberculous lymphadenitis |
-
2015
- 2015-07-23 CN CN201510438569.0A patent/CN104958486A/en active Pending
Non-Patent Citations (4)
| Title |
|---|
| 周祯祥等: "《张仲景药物学》", 31 January 2012, 中国医药科技出版社 * |
| 孟庆义等: "《急诊科典型病例分析》", 31 March 2004 * |
| 宁夏回族自治区农业科学研究所: "《科研成果汇编 畜牧兽医分册》", 31 December 1978 * |
| 杨小林等: "消肿散治疗淋巴结核12例", 《内蒙古中医药》 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105943790A (en) * | 2016-06-27 | 2016-09-21 | 蒋丁贵 | Traditional Chinese medicine for treating noxious pathogen attack and preparation method thereof |
| CN115154550A (en) * | 2022-07-26 | 2022-10-11 | 首都医科大学附属北京胸科医院 | External traditional Chinese medicine composition for treating ulcer type tuberculous lymphadenitis |
| CN115154550B (en) * | 2022-07-26 | 2023-09-01 | 首都医科大学附属北京胸科医院 | External traditional Chinese medicine composition for treating ulcerative tuberculosis |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102058781B (en) | Traditional Chinese medicinal film agent for treating burns and scalds | |
| CN103393916B (en) | External use ointment used for treating dermatitis and preparation method thereof | |
| CN103830478A (en) | Medicine for treatment of skin ulcer | |
| CN103893557A (en) | Traditional Chinese medicine preparation for treating bedsore | |
| CN101703651A (en) | Medicament for treating diabetic gangrene | |
| CN104958486A (en) | Traditional Chinese medicine for treating lymphatic tuberculosis | |
| CN102430036B (en) | Burn and scald antibacterial and pain-relieving ointment | |
| CN102274305A (en) | Detoxifying ointment prepared from Chinese herbal medicines | |
| CN102764360B (en) | Traditional Chinese medicine composition for treating acute cystitis | |
| CN102357215B (en) | Ointment for treating right hypochondriac distention and pain caused by acute and chronic cholecystitis | |
| CN103272028B (en) | A kind of medicine for the treatment of traumatic injury and rheumatic arthralgia | |
| CN102028771A (en) | Gromwell root and safflower ulcer ointment | |
| CN102526382B (en) | Plaster for relieving swelling and pain | |
| CN1283480A (en) | Medicine for treating piles | |
| CN105796744A (en) | Toxin-removal traditional Chinese medicine ointment | |
| CN104274617A (en) | Traditional Chinese medicine composition for nursing treatment of acute cervicitis | |
| CN104147261A (en) | Traditional Chinese medicine preparation for treating rheumatic arthritis | |
| CN104922614A (en) | Traditional Chinese medicine ointment for treating bedsores | |
| CN108524697A (en) | A kind of drug for treating prostatitis and hyperplasia | |
| CN103479822B (en) | Traditional Chinese unguent capable of preventing and treating wound infection and preparation method of traditional Chinese unguent | |
| CN1850224A (en) | Medicine for treating scald and burn and preparing method | |
| CN108245577B (en) | Ointment for relieving pain, eliminating swelling and promoting tissue regeneration of burn and preparation method thereof | |
| CN111053877A (en) | External-use swelling-eliminating pain-relieving ointment and preparation method and application thereof | |
| CN114159383A (en) | External traditional Chinese medicine for treating chronic refractory wound and preparation method thereof | |
| CN104888147A (en) | Traditional Chinese medicine ointment for shoulder periarthritis and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20151007 |
|
| RJ01 | Rejection of invention patent application after publication |